HTA and Access to Innovative Oncology Drugs in Europe

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

HTA and Access to Innovative Oncology Drugs in Europe | Brussels, 25 September 2018

Please fill in this form to register for the event on "Health Technology Assessment and Access to Innovative Oncology Drugs in Europe", organised by the European Cancer Patient Coalition in collaboration with the Cancer Drug Development Forum.

The event will take place in Brussels (Belgium) on Tuesday 25 September 2018 at 2:30 PM.

The event is free to attend and will be held at the European Parliament, Room A5E-2.

The agenda is available here:
https://goo.gl/89SiZD

Description:
Innovative healthcare drugs and therapies offer the potential to improve the lives of millions of people living with cancer in Europe, yet significant differences in time-to-access remain for most of the new therapeutic interventions. How to ensure effective innovations are accessible and affordable to all patients is a challenge facing all stakeholders in the field of cancer.

In light of the European Commission’s legislative proposal for future EU cooperation on Health Technology Assessment, the European Cancer Patient Coalition (ECPC) together with Elisabetta Gardini MEP (EPP, Italy) will host a high-level policy discussion organised in partnership with the Cancer Drug Development Forum (CDDF). The meeting will bring together patients, health stakeholders, academia, policymakers and industry to highlight the importance of a more harmonised approach to Health Technology Assessment for ensuring timely access to innovative oncology diagnostics and treatments, and equally for establishing a more meaningful and systematic involvement of patient organisations in the process.

Title *

Mrs

Other:

First Name *

Last Name *

Email *

Mobile Phone

Please include the country code. Example: +32 123456789

Organisation *

Position *

Further Information *

I agree to potentially appear in the event videos and pictures that may be used by the European Cancer Patient Coalition and/or Cancer Drug Development Forum to document the event. This includes: an event report (in print and online), which will be made available on ECPC/CDDF websites and shared via email with participants of this event; Social media communication on Twitter, Facebook, LinkedIn.

I understand, that my data will be processed by European Cancer Patient Coalition and Cancer Drug Development Forum, and will be shared with the European Parliament to process Visitor Access for non-accredited participants.

Required

Do you have accreditation to enter the European Parliament? *

Yes

No (Provide details on the next page)

Clear form

Never submit passwords through Google Forms.

This content is neither created nor endorsed by Google. Report Abuse - Terms of Service - Privacy Policy

Forms